Printer Friendly
The Free Library
19,604,538 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Atherotech to Present At UBS Warburg Global Life Sciences Conference; Presentation to be Webcast Live.


Business Editors & Health/Medical Writers

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Oct. 8, 2002

Atherotech, Inc., a leading cardiodiagnostic company and specialty reference laboratory, today announced that it will present at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Warburg Global Life Sciences Conference Tuesday, Oct. 8, 2002, at 11:00 a.m. (EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
). The presentation will be made by Roseanne Varner, Atherotech's president and chief executive officer. The UBS Warburg conference is being held Oct. 7-10 at The Plaza hotel in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

Investors will be able to listen to a live audio Webcast of Atherotech's presentation by accessing the UBS Warburg Web site (www.ubswarburg.com) and clicking on Events and Conferences in the lower right hand corner. A replay of the presentation will begin 3 hours after the live broadcast and will be available until Nov. 10, 2002.

Atherotech, Inc., developer of the VAP (Value Added Process) An executable program in a NetWare 2.x server. Starting with NetWare 3.x, VAPs were replaced by NLMs. See NetWare. (TM) (Vertical Auto Profile) Cholesterol Test Cholesterol Test Definition

The cholesterol test is a quantitative analysis of the cholesterol levels in a sample of the patient's blood. Total serum cholesterol (TC) is the measurement routinely taken.
, is dedicated to improving the prevention, early diagnosis, and treatment of heart disease and other cardiovascular diseases that kill nearly 1 million Americans each year. The VAP Test provides direct, detailed measurements of cholesterol, or lipid, subclasses that play important roles in the development of heart disease but are not measured by routine cholesterol tests, allowing physicians to improve patient detection and develop individualized treatment plans. The VAP Test, the new standard of care in cholesterol risk assessment, complies with recently released National Cholesterol Education Program The National Cholesterol Education Program is a program managed by the National Heart, Lung and Blood Institute, a division of the National Institutes of Health. Its goal is to reduce increased cardiovascular disease rates due to hypercholesterolemia (elevated cholesterol  guidelines. For more information, visit the company's Web site at www.atherotech.com.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Oct 8, 2002
Words:245
Previous Article:Docent Announces First Analytic Applications Suite to Link Employee, Partner and Customer Knowledge to Business Results.
Next Article:Epicyte Pharmaceutical Receives NIH Grant for Production of Hybrid Antibodies to Treat HIV.



Related Articles
Atherotech CEO to Present at UBS Warburg Global Life Sciences and Southeastern Bio Investors Conferences.
TransForm Pharmaceuticals to Present At Two Industry Conferences.
Cell Pathways to Present at UBS Warburg Global Life Sciences Conference.
XOMA To Deliver Corporate Update at UBS Warburg Life Sciences Conference.
Enzo Biochem to Make Presentation At UBS Warburg Global Life Sciences Conference.
Pall Corporation to Present at UBS Warburg Global Life Sciences Conference.
Diametrics Medical To Present at UBS Warburg Global Life Sciences Conference.
Acorda Therapeutics to Present at UBS Warburg Life Sciences Conference.
Transform Pharmaceuticals to Present at Two Industry Conferences.
Elusys Therapeutics to Present at UBS Warburg Global Life Sciences Conference on September 24, 2003.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles